Euro Results Round-Up: Karo Pharma And Recordati Post Double-Digit Gains
In the first-half of 2022, Sweden's Karo Pharma saw its sales rise by more than a third thanks to a combination of organic growth and acquisitions. Italy's Recordati reported OTC sales up by almost a fifth as the European market continued to recover post-COVID.
You may also be interested in...
Italy's Recordati reports a double-digit rise in OTC sales for the first quarter of 2022, reflecting improved sales of cold & flu products and dietary supplements, particularly in France and its domestic market.
Karo Pharma is poised to expand its portfolio in the UK with the acquisition of leading skin-care brand E45 from Reckitt.
Sweden's Karo Pharma is acquiring Sylphar Group and its dietary supplement and beauty brands sold around Europe, primarily online.